Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 14/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.61 |
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | SLC9A1 | P19634 | 4/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | GLA | P06280 | 3/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.61 |
| ▸ | SLC9A5 | Q14940 | 2/20 | 0.61 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.61 |
| ▸ | HTR1A | P08908 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10087508 | 0.89 | PLAU (0.63) | PLAUCYP1A2TSHRSLC9A1KDM4E | |
| Hydrochloric Acid SCHEMBL11618640 | 0.85 | PLAU (0.52) | PLAUCYP1A2TSHRSLC9A1KDM4E | |
| SCHEMBL15290919 | 0.84 | PLAU (0.67) | PLAUCYP1A2TSHRSLC9A1KDM4E | |
| SCHEMBL11612547 | 0.84 | PLAU (0.46) | PLAUCYP1A2TSHRSLC9A1KDM4E | |
| SCHEMBL11612556 | 0.84 | PLAU (0.46) | PLAUCYP1A2TSHRSLC9A1KDM4E | |
| SCHEMBL11586916 | 0.83 | PLAU (0.49) | PLAUCYP1A2TSHRSLC9A1KDM4E | |
| SCHEMBL11529204 | 0.82 | GRM5 (0.50) | PLAUCYP1A2TSHRSLC9A1KDM4E | |
| SCHEMBL11613699 | 0.82 | PLAU (0.47) | PLAUCYP1A2TSHRSLC9A1CYP2D6 | |
| SCHEMBL11465275 | 0.82 | PLAU (0.44) | PLAUCYP1A2TSHRSLC9A1KDM4E | |
| SCHEMBL11481176 | 0.82 | PLAU (0.44) | PLAUCYP1A2TSHRSLC9A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120108494-A1 | INHIBITORS OF INTRACELLULAR UROKINASE PLASMINOGEN ACTIVATOR AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108494-A1 | INHIBITORS OF INTRACELLULAR UROKINASE PLASMINOGEN ACTIVATOR AND METHODS OF USE THEREOF | PLAU, PLAUR, DNPEP | PLAU 1/4885CYP1A2 4875/4885TSHR 2353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.